A Multi-center, Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy of Subcutaneous Injections of the Myasthenia Gravis Active Targeted Immunotherapy CV-MG01 in Patients with Moderate to Severe Myasthenia Gravis - Myasterix Efficacy Phase 2/3 Study
100 Clinical Results associated with CuraVac Europe SA
0 Patents (Medical) associated with CuraVac Europe SA
100 Deals associated with CuraVac Europe SA
100 Translational Medicine associated with CuraVac Europe SA